Clinical Trial Update: A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of TAK-272 in participants with type 2 diabetes mellitus and microalbuminuria completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• TAK-272

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus and Microalbuminuria | Phase 2 | Status: COMPLETED | Results posted: 2018-08-13